- EU Generics Makers Demand “Clear, Open Market” (PharmaTimes)
- Sanofi-aventis, Minsheng Pharma Ink Deals to Form New Consumer Healthcare JV – Quick Facts (RTT News)
- Philippines to Announce Second Drug Price-Cut List (Bloomberg)
- AstraZeneca Cuts 8,000 jobs, No Big M&A Planned (PharmaTimes)
- Flexion Snags Pfizer Bucks, Three Pharma Deals, For New Drug Model (Xconomy)
- Drug Marketing Remains an Issue (The Wall Street Journal)
- B-MS Looking at Acquisitions and Definitely ‘Not for Sale’ (PharmaTimes)
- Franklin Co. Judge Awards $5.3 Million In Penalties against AstraZeneca (PharmaLive)
- Digital Pharma Europe at Bayer Schering Pharma Headquarters Berlin (World Pharma News)
- Gilead to buy back up to $1 billion in stock (Reuters)
- Merck, Pfizer Overcharged New York, Judge Rules (Bloomberg)
SUBSCRIBE